Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Heath

Showing results (361-370 of 425) with videos related to

Pageof 43
Sort By:
The Lancet. Infectious Diseases|May 9, 2026
Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trialNatasha Thorn, Zsofia Danos, Nick J Andrews, et al.
Health Technology Assessment (Winchester, England)|January 20, 2012
A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in childrenP de Whalley, W Walker, M D Snape, et al.
Vaccine|August 26, 2025
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006)Grace Li, Natalie G Marchevsky, Grace Macaulay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2017
Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analysesNeal J Russell, Anna C Seale, Catherine O'Sullivan, et al.
Open Forum Infectious Diseases|March 12, 2025
Etiology and Antimicrobial Resistance of Culture-Positive Infections in Ugandan Infants: A Cohort Study of 7000 Neonates and InfantsHannah G Davies, Mary Kyohere, Valerie Tusubira, et al.
The Journal of Infection|March 29, 2024
Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiologyN G Martin, S Defres, L Willis, et al.
The Lancet. Respiratory Medicine|November 20, 2021
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trialSeth Toback, Eva Galiza, Catherine Cosgrove, et al.
Archives of Disease in Childhood|July 8, 2024
An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infantsAnna Calvert, Nick Andrews, Sheula Barlow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2017
Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analysesFiorella Bianchi-Jassir, Anna C Seale, Maya Kohli-Lynch, et al.
Expert Review of Vaccines|May 29, 2023
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccineEddie Underwood, Lisa M Dunkle, Shabir A Madhi, et al.
Pageof 43

Showing results (361-370 of 425) with videos related to

Sort By:
Pageof 43
The Lancet. Infectious Diseases|May 9, 2026
Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trialNatasha Thorn, Zsofia Danos, Nick J Andrews, et al.
Health Technology Assessment (Winchester, England)|January 20, 2012
A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in childrenP de Whalley, W Walker, M D Snape, et al.
Vaccine|August 26, 2025
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006)Grace Li, Natalie G Marchevsky, Grace Macaulay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2017
Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analysesNeal J Russell, Anna C Seale, Catherine O'Sullivan, et al.
Open Forum Infectious Diseases|March 12, 2025
Etiology and Antimicrobial Resistance of Culture-Positive Infections in Ugandan Infants: A Cohort Study of 7000 Neonates and InfantsHannah G Davies, Mary Kyohere, Valerie Tusubira, et al.
The Journal of Infection|March 29, 2024
Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiologyN G Martin, S Defres, L Willis, et al.
The Lancet. Respiratory Medicine|November 20, 2021
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trialSeth Toback, Eva Galiza, Catherine Cosgrove, et al.
Archives of Disease in Childhood|July 8, 2024
An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infantsAnna Calvert, Nick Andrews, Sheula Barlow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2017
Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analysesFiorella Bianchi-Jassir, Anna C Seale, Maya Kohli-Lynch, et al.
Expert Review of Vaccines|May 29, 2023
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccineEddie Underwood, Lisa M Dunkle, Shabir A Madhi, et al.
Pageof 43